| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |